50 results on '"Zhu, Hengrui"'
Search Results
2. Challenges in quasinormal mode extraction: Perspectives from numerical solutions to the Teukolsky equation
3. Analysis of Object Phase Transition Process Based on Image Segmentation and Graph Neural Network
4. Geochronology and geochemistry of ore-hosted zircon reveal the genesis of typical Sb-(Au-W) deposits in South China
5. Table S2 from BET Inhibitors Suppress ALDH Activity by Targeting ALDH1A1 Super-Enhancer in Ovarian Cancer
6. Figure S2 from BET Inhibitors Suppress ALDH Activity by Targeting ALDH1A1 Super-Enhancer in Ovarian Cancer
7. Table S3 from BET Inhibitors Suppress ALDH Activity by Targeting ALDH1A1 Super-Enhancer in Ovarian Cancer
8. Figure S5 from BET Inhibitors Suppress ALDH Activity by Targeting ALDH1A1 Super-Enhancer in Ovarian Cancer
9. Figure S4 from BET Inhibitors Suppress ALDH Activity by Targeting ALDH1A1 Super-Enhancer in Ovarian Cancer
10. Table S3 from BET Inhibitors Suppress ALDH Activity by Targeting ALDH1A1 Super-Enhancer in Ovarian Cancer
11. Suppl Info from BET Inhibitors Suppress ALDH Activity by Targeting ALDH1A1 Super-Enhancer in Ovarian Cancer
12. Figure S4 from BET Inhibitors Suppress ALDH Activity by Targeting ALDH1A1 Super-Enhancer in Ovarian Cancer
13. Figure S1 from BET Inhibitors Suppress ALDH Activity by Targeting ALDH1A1 Super-Enhancer in Ovarian Cancer
14. Table S1 from BET Inhibitors Suppress ALDH Activity by Targeting ALDH1A1 Super-Enhancer in Ovarian Cancer
15. Figure S3 from BET Inhibitors Suppress ALDH Activity by Targeting ALDH1A1 Super-Enhancer in Ovarian Cancer
16. Data from BET Inhibitors Suppress ALDH Activity by Targeting ALDH1A1 Super-Enhancer in Ovarian Cancer
17. Figure S3 from BET Inhibitors Suppress ALDH Activity by Targeting ALDH1A1 Super-Enhancer in Ovarian Cancer
18. Figure S6 from BET Inhibitors Suppress ALDH Activity by Targeting ALDH1A1 Super-Enhancer in Ovarian Cancer
19. Table S1 from BET Inhibitors Suppress ALDH Activity by Targeting ALDH1A1 Super-Enhancer in Ovarian Cancer
20. Figure S1 from BET Inhibitors Suppress ALDH Activity by Targeting ALDH1A1 Super-Enhancer in Ovarian Cancer
21. Suppl Info from BET Inhibitors Suppress ALDH Activity by Targeting ALDH1A1 Super-Enhancer in Ovarian Cancer
22. Table S2 from BET Inhibitors Suppress ALDH Activity by Targeting ALDH1A1 Super-Enhancer in Ovarian Cancer
23. Data from BET Inhibitors Suppress ALDH Activity by Targeting ALDH1A1 Super-Enhancer in Ovarian Cancer
24. Adaptive analytical ray tracing of black hole photon rings
25. Research and analysis of base station optimal location model based on cluster analysis
26. Detection of the Ubiquitinome in Cells Undergoing Oncogene-Induced Senescence
27. Probing the Local Interstellar Medium with Scintillometry of the Bright Pulsar B1133 + 16
28. FLT3 inhibition by olverembatinib (HQP1351) downregulates MCL-1 and synergizes with BCL-2 inhibitor lisaftoclax (APG-2575) in preclinical models of FLT3-ITD mutant acute myeloid leukemia
29. Abstract 1096: FMS-like tyrosine kinase 3 (FLT3) inhibition by olverembatinib (HQP1351) downregulates MCL-1 and synergizes with BCL-2 inhibitor APG-2575 in preclinical models of FLT3-mutant acute myeloid leukemia (AML)
30. Deconvolving Pulsar Signals with Cyclic Spectroscopy: A Systematic Evaluation
31. Scintillation Arcs in Pulsar B0450–18
32. Abstract NT-093: THE N6-METHYLATION OF ADENOSINE (M6A) IN FZD10 MRNA CONTRIBUTES TO RESISTANCE TO PARP INHIBITOR
33. N6-Methylation of Adenosine of FZD10 mRNA Contributes to PARP Inhibitor Resistance
34. Pyramidatine (Z88) Sensitizes Vincristine-Resistant Human Oral Cancer (KB/VCR) Cells to Chemotherapeutic Agents by Inhibition of P-glycoprotein
35. CARM1-expressing ovarian cancer depends on the histone methyltransferase EZH2 activity
36. BET Bromodomain Inhibition Synergizes with PARP Inhibitor in Epithelial Ovarian Cancer
37. Abstract AP31: TARGETING PD–L1/PD1 PATHWAY THROUGH BET PROTEIN INHIBITION IN EPITHELIAL OVARIAN CANCER
38. The chromatin organizer SATB1 governs the epigenetic repression of the co-inhibitory receptor PD-1 in T cells
39. Beyond immune suppression: the intrinsic function of PD-L1 in ovarian cancer and melanoma
40. SATB1 Expression Governs Epigenetic Repression of PD-1 in Tumor-Reactive T Cells
41. BET Inhibitors Suppress ALDH Activity by Targeting ALDH1A1 Super-Enhancer in Ovarian Cancer
42. BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression
43. Shizukaol D, a Dimeric Sesquiterpene Isolated from Chloranthus serratus, Represses the Growth of Human Liver Cancer Cells by Modulating Wnt Signalling Pathway
44. SPOP E3 Ubiquitin Ligase Adaptor Promotes Cellular Senescence by Degrading the SENP7 deSUMOylase
45. A novel role for the condensin II complex in cellular senescence
46. Comprehensive analysis of the ubiquitinome during oncogene-induced senescence in human fibroblasts
47. In vitro and in vivo characterization of a benzofuran derivative, a potential anticancer agent, as a novel Aurora B kinase inhibitor
48. Reversal of P-gp and MRP1-mediated multidrug resistance by H6, a gypenoside aglycon from Gynostemma pentaphyllum, in vincristine-resistant human oral cancer (KB/VCR) cells
49. Cyclophilin A promotes human hepatocellular carcinoma cell metastasis via regulation of MMP3 and MMP9
50. Interaction of Sedlin with PAM14
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.